Search Grant Opportunities

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

ID: RFA-CA-25-001 • Type: Posted

Description

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. The emphasis of this NOFO is on supporting the development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology. Technologies proposed for development may be intended to have widespread applicability but must be focused on improving molecular and/or cellular characterizations of cancer biology. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, or epidemiology, and/or address issues associated with cancer health disparities. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
Background
The National Cancer Institute (NCI) of the National Institutes of Health (NIH) is issuing this Notice of Funding Opportunity (NOFO) to solicit grant applications for exploratory research projects focused on the early-stage development of innovative technologies that provide novel molecular or cellular analysis capabilities for cancer research.

This initiative aims to support projects that enhance understanding and characterization of cancer biology, improve early detection and screening, clinical diagnosis, treatment, and address cancer health disparities. This funding opportunity is part of the broader Innovative Molecular Analysis Technologies (IMAT) Program, which has been operational since 1998 and focuses on advancing innovative technologies in cancer research.

Grant Details
The grant supports exploratory research projects that propose the development of highly innovative technologies aimed at improving molecular and cellular characterizations of cancer biology. Applications must focus on:
1. The development of novel tools with substantial improvements over current approaches or new technical capabilities.
2. Technologies that can significantly impact laboratory, epidemiology, or clinical settings.
3. A rigorous study design with verifiable performance measures.
4. Projects must not pursue existing technologies without substantial modifications or focus primarily on biological questions without a novel technical component.
5. The proposed technology should target molecular or cellular features relevant to cancer biology and demonstrate potential for widespread applicability.

Eligibility Requirements
Eligible applicants include higher education institutions, public/state controlled institutions, private institutions, nonprofits, for-profit organizations (including small businesses), local governments, state governments, tribal governments, federal agencies, foreign organizations, and other entities such as independent school districts and faith-based organizations. Individuals from diverse backgrounds are encouraged to apply.

Period of Performance
The total project period may not exceed 3 years. Specific timelines for application submission and award cycles are outlined in the grant announcement.

Grant Value
NCI intends to fund an estimated 17 awards totaling $4,200,000 for fiscal year 2026. Individual application budgets are limited to $150,000 per year in direct costs.

Overview

Category of Funding
Education
Health
Funding Instruments
Grant
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 12/16/24 the National Institutes of Health posted grant opportunity RFA-CA-25-001 for Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) with funding of $150,000. The grant will be issued under grant program 93.394 Cancer Detection and Diagnosis Research. It is expected that 17 total grants will be made.

Timing

Posted Date
Dec. 16, 2024, 12:00 a.m. EST
Closing Date
Oct. 3, 2025, 12:00 a.m. EDT Due in 155 Days
Last Updated
Dec. 16, 2024, 11:25 a.m. EST
Version
1
Archive Date
Nov. 8, 2025

Eligibility

Eligible Applicants
City or township governments
State governments
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Award Sizing

Ceiling
$150,000
Floor
Not Listed
Estimated Program Funding
$150,000
Estimated Number of Grants
17

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-25-001.html

Documents

Posted documents for RFA-CA-25-001

Potential Applicants and Partners

Awardees that have recently won grants similar to RFA-CA-25-001

Incumbent or Similar Grants

Grants similar to RFA-CA-25-001

Similar Active Opportunities

Open grant opportunities similar to RFA-CA-25-001